
Journal of the Chemical Society, Dalton Transactions p. 3571 - 3574 (1996)
Update date:2022-08-03
Topics:
Braunstein, Pierre
Pietsch, Joerg
Chauvin, Yves
Mercier, Sophie
Saussine, Lucien
DeCian, Andre
Fischer, Jean
The complexes [NiPh{Ph2PCH-??C(- ??NPh)Ph}{Ph3P=CHC(=NPh)Ph-N}] and [NiPh{Ph2PCH-??C(- ??NPh)Ph}-(PR3)] (PR3 = PMe3, PMe2Ph or PMePh2) were prepared starting from [Ni(cod)2] (cod = cycloocta-1,5-diene) and the phosphorus ylide Ph3P=CHC(=NPh)Ph I in the presence of a tertiary phosphine. Surprisingly, only the first complex was isolated when PPh3 and P(C6H11)3 were used, whereas the other phosphines led to the corresponding PR3 complexes together with variable amounts of the first depending on their steric demand. The known synthesis of I has been optimized to yields close to 90%. Experiments carried out to study the potential of the nickel compounds as catalysts for ethylene oligomerization showed the stoichiometric formation of styrene and minor amounts of low-molecular-weight linear α-olefins. The molecular structures of I and the first complex have been determined by X-ray diffraction. In the nickel complex the coordination around the metal is distorted square planar, with P(1)-Ni-C(1) and N(1)-Ni-N(2) angles of 90.30(8) and 97.18(8)°, respectively.
View MoreContact:+86 512 6287 2180
Address:398 Ruoshui Road, Suzhou Industrial Park, Suzhou, Jiangsu, P. R. China
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Shanghai Korey Pharm Co.,Ltd.(expird)
Contact:021-61840961 021-61840962
Address:No.157,Zhuguang Rd, Qingpu, Shanghai, China
Taizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
AstaTech ( Chengdu) BioPharmaceutical Corp.
website:http://www.astabiochem.cn/
Contact:+86-15198215156-15198215156
Address:SICHUAN CHENGDU
Doi:10.1080/00369220018737102
(1967)Doi:10.1016/0040-4020(96)00806-X
(1996)Doi:10.1002/anie.199623591
(1996)Doi:10.1021/ja960872u
(1997)Doi:10.1039/c8ob00464a
(2018)Doi:10.1002/adsc.202000586
(2020)